ABSTRACT
Se realiza una revisión de estudios de resonancia magnética integral y funcional, así como estudios bioquímicos en pacientes con y sin ideas suicidas. Estos estudios en pacientes con alto riesgo de suicidio presentan una disminución de volúmenes corticales en la corteza prefrontal dorso y ventrolateral. Lo importante de estos estudios es que resultan de la comparación con pacientes deprimidos con bajo riesgo de suicidio. Los estudios de resonancia magnética funcional mostraron una hipofuncionalidad del lóbulo prefrontal en los pacientes depresivos con ideas suicidas severas, que se observa como una disminución del flujo sanguíneo cerebral en las áreas lateral y ventral. Se observa una disminución del metabolismo de serotonina, en clara relación con la severidad de las ideas de muerte, también con un foco en la región lateroventral prefrontal. Dado que las funciones de la corteza prefrontal afirman al individuo en su perspectiva vital, disfunciones como las descritas debilitan la coordinación y organización del apego a la vida, quedando, por el contrario, la posibilidad de la búsqueda de la muerte. Se concluye que los pacientes depresivos con ideas suicidas tienen una alta vulnerabilidad para el intento de suicidio por la afectación de las zonas prefrontales.
A review of functional integral magnetic resonance and biochemical data from patients with and without suicidal ideation is presented. Patients with high suicidal risk show a decrease in cortical volume in ventrolateral and dorsal prefrontal cortex. These studies are compared to those of depressed patients with low suicidal risk. Functional magnetic resonance in depressed patients with severe suicidal ideation show an hypo functional prefrontal lobe, seen as a decrease in blood flow in lateral and ventral areas. There is a decrease in serotonin metabolism, clearly related to the severity of suicidal ideation, also in ventrolateral prefrontal cortex. As prefrontal cortex functions enhance vital perspectives, such dysfunctions weaken coordination and organization of attachment to life, making search for death a possibility. Authors conclude that depressed patients with suicidal ideation have a high vulnerability for suicidal intent due to changes in prefrontal areas.
Subject(s)
Humans , Suicide, Attempted , Prefrontal Cortex/physiopathology , Neurotransmitter Agents/metabolism , Depression/physiopathology , Suicidal Ideation , Magnetic Resonance Imaging , Prefrontal Cortex/metabolism , Prefrontal Cortex/diagnostic imaging , Depression/metabolismABSTRACT
Studies have shown that an injection with the histamine H4 receptor agonist VUF-8430 modulates emotional memory processes. In the present study, the aim was to verify if intraperitoneal (ip) injection of VUF-8430 (500 ng/kg) in mice affects the synthesis of proteins required for memory consolidation processes by activating the phosphorylation of CREB (pCREB) in classical structures linked to emotional memory (prefrontal cortex, amygdala, and hippocampus) and the cerebellar vermis, a structure that has also been recently implicated in emotional memory. The results obtained using western blot analysis demonstrated that VUF-8430 induced a decrease in CREB and pCREB levels in the cerebellar vermis and prefrontal cortex, suggesting that this dose impaired the activation of cell signaling pathways in these structures. There was no change in protein expression in the amygdala and hippocampus. Our results are preliminary, and further investigations are needed to investigate the role of the H4 receptors in the central nervous system.
Subject(s)
Animals , Male , Rabbits , Prefrontal Cortex/metabolism , Cerebellar Vermis/metabolism , Receptors, Histamine H4/metabolism , Memory/physiology , Phosphorylation , Stress, Physiological , Prefrontal Cortex/drug effects , Disease Models, Animal , Emotions , Cerebellar Vermis/drug effects , Memory Consolidation/physiology , Hippocampus , Histamine Antagonists/pharmacologyABSTRACT
Objective: Cognitive impairment is a core feature of schizophrenia, related to dopaminergic dysfunction in the prefrontal cortex (PFC). It is hypothesized that functional single nucleotide polymorphism (SNP) rs4680 of the catechol-O-methyltransferase (COMT) gene could mediate the relationship between cognition and dopamine activity in the PFC. Other COMT SNPs could also play a role. Methods: We evaluated the role of three COMT SNPs (rs737865, rs165599, and rs4680) in schizophrenia and their impact on three working memory tasks. For genetic association analyses, 212 individuals with schizophrenia and 257 healthy controls (HCs) were selected. The Visual Working Memory (VWM) Task, Keep Track Task, and Letter Memory Task were administered to 133 schizophrenics and 93 HCs. Results: We found a significant association of rs737865, with the GG genotype exerting a protective effect and the GA haplotype (rs4680/rs165599) exerting a risk effect for schizophrenia. COMT rs4680 AA carriers and rs737865 AA carriers scored lowest on the Keep Track Task. When the genotype*group interaction effect was evaluated, rs165599 exerted opposite effects for VWM and Keep Track task performance in patients and controls, with AA carriers scoring lowest on both tests among controls, but highest among patients. Conclusion: These data support the hypothesis that COMT polymorphisms may be associated with schizophrenia and modulate cognition in patients and controls.
Subject(s)
Humans , Male , Female , Adult , Schizophrenia/genetics , Catechol O-Methyltransferase/genetics , Prefrontal Cortex/metabolism , Memory, Short-Term/physiology , Phenotype , Schizophrenia/physiopathology , Schizophrenia/metabolism , Haplotypes , Catechol O-Methyltransferase/metabolism , Case-Control Studies , Genetic Predisposition to Disease , Polymorphism, Single Nucleotide/genetics , Gene Frequency , Genotype , Neuropsychological TestsABSTRACT
Abstract Introduction: Agonistic behaviors help to ensure survival, provide advantage in competition, and communicate social status. The resident-intruder paradigm, an animal model based on male intraspecific confrontations, can be an ethologically relevant tool to investigate the neurobiology of aggressive behavior. Objectives: To examine behavioral and neurobiological mechanisms of aggressive behavior in male Swiss mice exposed to repeated confrontations in the resident intruder paradigm. Methods: Behavioral analysis was performed in association with measurements of plasma corticosterone of mice repeatedly exposed to a potential rival nearby, but inaccessible (social instigation), or to 10 sessions of social instigation followed by direct aggressive encounters. Moreover, corticotropin-releasing factor (CRF) and brain-derived neurotrophic factor (BNDF) were measured in the brain of these animals. Control mice were exposed to neither social instigation nor aggressive confrontations. Results: Mice exposed to aggressive confrontations exhibited a similar pattern of species-typical aggressive and non-aggressive behaviors on the first and the last session. Moreover, in contrast to social instigation only, repeated aggressive confrontations promoted an increase in plasma corticosterone. After 10 aggressive confrontation sessions, mice presented a non-significant trend toward reducing hippocampal levels of CRF, which inversely correlated with plasma corticosterone levels. Conversely, repeated sessions of social instigation or aggressive confrontation did not alter BDNF concentrations at the prefrontal cortex and hippocampus. Conclusion: Exposure to repeated episodes of aggressive encounters did not promote habituation over time. Additionally, CRF seems to be involved in physiological responses to social stressors.
Resumo Introdução: Comportamentos agonísticos ajudam a garantir a sobrevivência, oferecem vantagem na competição e comunicam status social. O paradigma residente-intruso, modelo animal baseado em confrontos intraespecíficos entre machos, pode ser uma ferramenta etológica relevante para investigar a neurobiologia do comportamento agressivo. Objetivos: Analisar os mecanismos comportamentais e neurobiológicos do comportamento agressivo em camundongos Swiss machos expostos a confrontos repetidos no paradigma residente-intruso. Métodos: A análise comportamental foi realizada em associação com medidas de corticosterona plasmática em camundongos expostos repetidamente a um rival em potencial próximo, porém inacessível (instigação social), ou a 10 sessões de instigação social seguidas de encontros agressivos diretos. Além disso, o fator de liberação de corticotrofina (CRF) e o fator neurotrófico derivado do cérebro (BNDF) foram medidos no encéfalo desses animais. Camundongos controles não foram expostos à instigação social ou confrontos agressivos. Resultados: Os camundongos expostos a confrontos agressivos exibiram um padrão semelhante de comportamentos agressivos e não agressivos típicos da espécie na primeira e na última sessão. Em contraste com instigação social apenas, confrontos agressivos repetidos promoveram aumento na corticosterona plasmática. Após 10 sessões de confrontos agressivos, os camundongos apresentaram uma tendência não significativa de redução dos níveis de CRF no hipocampo, que se correlacionaram inversamente com os níveis plasmáticos de corticosterona. Por outro lado, sessões repetidas de instigação social ou confronto agressivo não alteraram as concentrações de BDNF no córtex pré-frontal e hipocampo. Conclusão: A exposição a episódios repetidos de encontros agressivos não promoveu habituação ao longo do tempo. Adicionalmente, o CRF parece estar envolvido nas respostas fisiológicas aos estressores sociais.
Subject(s)
Animals , Male , Corticosterone/blood , Corticotropin-Releasing Hormone/metabolism , Prefrontal Cortex/metabolism , Brain-Derived Neurotrophic Factor/metabolism , Aggression/physiology , Limbic System/metabolism , Behavior, Animal/physiology , Enzyme-Linked Immunosorbent Assay , Analysis of Variance , Habituation, Psychophysiologic/physiology , Housing, Animal , MiceABSTRACT
Objective:To investigate the effects of ethanol exposure in adolescent rats during adulthood by assesssing aggression and anxiety-like behaviors and measuring the levels of inflammatory markers.Methods:Groups of male Wistar rats (mean weight 81.4 g, n = 36) were housed in groups of four until postnatal day (PND) 60. From PNDs 30 to 46, rats received one of three treatments: 3 g/kg of ethanol (15% w/v, orally, n = 16), 1.5 g/kg of ethanol (12.5% w/v, PO, n = 12), or water (n = 12) every 48 hours. Animals were assessed for aggressive behavior (resident x intruder test) and anxiety-like behaviors (elevated plus maze) during adulthood.Results:Animals that received low doses of alcohol showed reduced levels of brain-derived neurotrophic factor (BDNF) in the hippocampus as compared to the control group. No significant difference was found in prefrontal cortex.Conclusions:Intermittent exposure to alcohol during adolescence is associated with lower levels of BDNF in the hippocampus, probably due the episodic administration of alcohol, but alcohol use did not alter the level agression toward a male intruder or anxiety-like behaviors during the adult phase.
Objetivo: Investigar os efeitos da exposição ao etanol em ratos adolescentes durante a idade adulta sobre os comportamentos agressivos e semelhantes à ansiedade, bem como sobre as medidas de níveis de marcadores inflamatórios.Métodos:Os grupos de ratos Wistar machos (peso médio de 81,4 g; n = 36) foram alojados em grupos de quatro até o dia pós-natal (DPN) 60. Entre os DPNs 30 e 46, os ratos receberam um dos três tratamentos: 3 g/kg de etanol (15% w/v, oralmente, n = 16), 1.5 g/kg de etanol (12,5% w/v, oralmente, n = 12), ou água (n = 12) a cada 48 horas. Os comportamentos agressivos (teste residente-intruso) e semelhantes à ansiedade (labirinto em cruz elevado) foram avaliados durante a idade adulta dos animais.Resultados:Os animais que receberam doses menores de álcool mostraram níveis reduzidos de fator neurotrófico derivado do cérebro (BDNF) no hipocampo quando comparados ao grupo controle. Nenhuma diferença significativa foi verificada no córtex pré-frontal.Conclusões:A exposição intermitente ao álcool durante a adolescência é associada com menores níveis de BDNF no hipocampo, provavelmente divido a administração episódica de álcool, mas o uso não alterou o nível de agressão contra o macho intruso ou os comportamentos semelhantes à ansiedade durante a fase adulta.
Subject(s)
Animals , Male , Central Nervous System Depressants/administration & dosage , Ethanol/administration & dosage , Binge Drinking/metabolism , Binge Drinking/psychology , Hippocampus/growth & development , Hippocampus/drug effects , Anxiety/physiopathology , Risk-Taking , Central Nervous System Depressants/adverse effects , Tumor Necrosis Factor-alpha/metabolism , Interleukin-10/metabolism , Rats, Wistar , Prefrontal Cortex/growth & development , Prefrontal Cortex/drug effects , Prefrontal Cortex/metabolism , Brain-Derived Neurotrophic Factor/metabolism , Aggression/drug effects , Aggression/physiology , Aggression/psychology , Disease Models, Animal , Ethanol/adverse effects , Dose-Response Relationship, Drug , Interleukin-1alpha/metabolism , Hippocampus/metabolismABSTRACT
Introduction Auditory neuropathy/dyssynchrony (AN/AD) comprises a spectrum of pathology affecting the auditory pathways anywhere from the inner hair cells to the brainstem. It is characterized by an absent or atypical auditory brainstem response (ABR) with preservation of the cochlear microphonics and/or otoacoustic emissions (OAEs). Objective Retrospective analysis of patients with AN/AD. Methods Fifteen patients with AN/AD were included in this study and their records were retrospectively investigated. Results Possible etiology of AN/AD was neonatal hyperbilirubinemia in three patients, family history of hearing loss in three patients, consanguineous marriage in two patients, head trauma in two patients, mental motor retardation in one patient, cerebrovascular disease in one patient, and there was no apparent cause in three patients. Conclusion Otolaryngologists should keep in mind the diagnosis of AN/AD especially in patients complaining of difficulty in hearing and speech and audiological evidence of disassociation between pure tone and speech audiometry. ABR and OAE testing is recommended in these patients for AN/AD diagnosis. .
Subject(s)
Female , Humans , Male , Brain/metabolism , Epigenesis, Genetic , Klinefelter Syndrome/genetics , Transcriptome , Alu Elements , Case-Control Studies , Cerebellum/metabolism , DNA Methylation , Klinefelter Syndrome/complications , Klinefelter Syndrome/metabolism , Long Interspersed Nucleotide Elements , Prefrontal Cortex/metabolism , Schizophrenia/complicationsABSTRACT
Objective: In the present study, we aimed to examine the effects of repeated D-amphetamine (AMPH) exposure, a well-accepted animal model of acute mania in bipolar disorder (BD), and histone deacetylase (HDAC) inhibitors on locomotor behavior and HDAC activity in the prefrontal cortex (PFC) and peripheral blood mononuclear cells (PBMCs) of rats. Moreover, we aimed to assess brain-derived neurotrophic factor (BDNF) protein and mRNA levels in these samples. Methods: We treated adult male Wistar rats with 2 mg/kg AMPH or saline intraperitoneally for 14 days. Between the 8th and 14th days, rats also received 47.5 mg/kg lithium (Li), 200 mg/kg sodium valproate (VPT), 2 mg/kg sodium butyrate (SB), or saline. We evaluated locomotor activity in the open-field task and assessed HDAC activity in the PFC and PBMCs, and BDNF levels in the PFC and plasma. Results: AMPH significantly increased locomotor activity, which was reversed by all drugs. This hyperactivity was associated with increased HDAC activity in the PFC, which was partially reversed by Li, VPT, and SB. No differences were found in BDNF levels. Conclusion: Repeated AMPH administration increases HDAC activity in the PFC without altering BDNF levels. The partial reversal of HDAC increase by Li, VPT, and SB may account for their ability to reverse AMPH-induced hyperactivity. .
Subject(s)
Animals , Male , Brain-Derived Neurotrophic Factor/analysis , Dextroamphetamine/pharmacology , Dopamine Uptake Inhibitors/pharmacology , Histone Deacetylases/analysis , Motor Activity/drug effects , Prefrontal Cortex/drug effects , Analysis of Variance , Antimanic Agents/pharmacology , Bipolar Disorder/drug therapy , Bipolar Disorder/metabolism , Brain-Derived Neurotrophic Factor/drug effects , Butyric Acid/pharmacology , Disease Models, Animal , Histone Deacetylases/drug effects , Lithium/pharmacology , Prefrontal Cortex/metabolism , Rats, Wistar , Real-Time Polymerase Chain Reaction , Valproic Acid/pharmacologyABSTRACT
Objective: To evaluate behavioral changes and brain-derived neurotrophic factor (BDNF) levels in rats subjected to ketamine administration (25 mg/kg) for 7 days. Method: Behavioral evaluation was undertaken at 1 and 6 hours after the last injection. Results: We observed hyperlocomotion 1 hour after the last injection and a decrease in locomotion after 6 hours. Immobility time was decreased and climbing time was increased 6 hours after the last injection. BDNF levels were decreased in the prefrontal cortex and amygdala when rats were killed 6 hours after the last injection, compared to the saline group and to rats killed 1 hour after the last injection. BDNF levels in the striatum were decreased in rats killed 6 hours after the last ketamine injection, and BDNF levels in the hippocampus were decreased in the groups that were killed 1 and 6 hours after the last injection. Conclusion: These results suggest that the effects of ketamine on behavior and BDNF levels are related to the time at which they were evaluated after administration of the drug. .
Subject(s)
Animals , Male , Rats , Anesthetics, Dissociative/administration & dosage , Brain-Derived Neurotrophic Factor/metabolism , Brain/drug effects , Ketamine/administration & dosage , Amygdala/drug effects , Amygdala/metabolism , Brain/metabolism , Corpus Striatum/drug effects , Corpus Striatum/metabolism , Disease Models, Animal , Hippocampus/drug effects , Hippocampus/metabolism , Motor Activity/drug effects , Prefrontal Cortex/drug effects , Prefrontal Cortex/metabolism , Rats, Wistar , Swimming , Time FactorsABSTRACT
It has been demonstrated that exposure to a variety of stressful experiences enhances fearful reactions when behavior is tested in current animal models of anxiety. Until now, no study has examined the neurochemical changes during the test and retest sessions of rats submitted to the elevated plus maze (EPM). The present study uses a new approach (HPLC) by looking at the changes in dopamine and serotonin levels in the prefrontal cortex, amygdala, dorsal hippocampus, and nucleus accumbens in animals upon single or double exposure to the EPM (one-trial tolerance). The study involved two experiments: i) saline or midazolam (0.5 mg/kg) before the first trial, and ii) saline or midazolam before the second trial. For the biochemical analysis a control group injected with saline and not tested in the EPM was included. Stressful stimuli in the EPM were able to elicit one-trial tolerance to midazolam on re-exposure (61.01 percent). Significant decreases in serotonin contents occurred in the prefrontal cortex (38.74 percent), amygdala (78.96 percent), dorsal hippocampus (70.33 percent), and nucleus accumbens (73.58 percent) of the animals tested in the EPM (P < 0.05 in all cases in relation to controls not exposed to the EPM). A significant decrease in dopamine content was also observed in the amygdala (54.74 percent, P < 0.05). These changes were maintained across trials. There was no change in the turnover rates of these monoamines. We suggest that exposure to the EPM causes reduced monoaminergic neurotransmission activity in limbic structures, which appears to underlie the "one-trial tolerance" phenomenon.
Subject(s)
Animals , Male , Rats , Anxiety/metabolism , Anti-Anxiety Agents/pharmacology , Maze Learning/drug effects , Dopamine/metabolism , Brain/metabolism , Midazolam/pharmacology , Serotonin/metabolism , Amygdala/metabolism , Chromatography, High Pressure Liquid , Prefrontal Cortex/metabolism , Brain/drug effects , Hippocampus/metabolism , Nucleus Accumbens/metabolism , Rats, WistarABSTRACT
To investigate the effect of thiopental sodium on the release of glutamate and gamma-aminobutyric acid (GABA) from synaptosomes in the prefrontal cortex, synaptosomes were made, the spontaneous release and the evoked release by 30 mmol/L KCl or 20 micromol/L veratridine of glutamate and GABA were performed under various concentrations of thiopental sodium (10-300 micromol/L), glutamate and GABA concentrations were determined by reversed-phase high-performance liquid chromatography. Our results showed that spontaneous release and evoked release of glutamate were significantly inhibited by 30 micromol/L, 100 micromol/L and 300 micromol/L thiopental sodium, IC50 of thiopental sodium was 25.8 +/- 2.3 micromol/L for the spontaneous release, 23.4 +/- 2.4 micromol/L for KCl-evoked release, and 24.3 +/- 1.8 micromol/L for veratridine-evoked release. But GABA spontaneous release and evoked release were unaffected. The study showed that thiopental sodium with clinically related concentrations could inhibit the release of glutamate, but had no effect on the release of GABA from rats prefrontal cortical synaptosomes.
Subject(s)
Glutamic Acid/metabolism , Hypnotics and Sedatives/pharmacology , Prefrontal Cortex/metabolism , Rats, Sprague-Dawley , Synaptosomes/metabolism , Thiopental/pharmacology , gamma-Aminobutyric Acid/metabolismABSTRACT
O córtex pré-frontal dorso-lateral (CPFDL) é uma das regiões cerebrais envolvidas no controle e expressão das emoções. Postula-se que alterações no funcionamento do CPFDL ocorram em pacientes com transtorno afetivo bipolar, e tenham relevância à fisiopatologia desse transtorno. A espectroscopia por ressonância magnética de prótons (ERM-'ANTPOT 1 H') permite medir a concentração de diversos metabólitos cerebrais de forma não invasiva. Entre os metabólitos de maior interesse estão o N-acetil-aspartato (NAA) e o inositol, marcadores do funcionamento neuronal e possivelmente relevantes nas ações benéficas do lítio. O presente protocolo avaliou o CPFDL de pacientes bipolares adultos e adolescentes utilizando ERM-'ANTPOT 1 H') para identificar possíveis alterações na concentração de NAA ou inositol entre os pacientes.The dorsolateral prefrontal cortex (DLPFC) is one of the brain regions involved on the expression and control of emotions. It is believed that patients with Bipolar Affective Disorder present an abnormal functioning of the DLPFC, which might be relevant to the illness pathophysiology. Proton magnetic resonance spectroscopy ('ANTPOT 1 H'-MRS) is a non-invasive techique that alows us to measure the concentration of several brain metabolites. Some relevant metabolites are N-Acetyl-Aspartate (NAA) and inositol, two markers of neural functioning that might also be involved on lithium's therapeutic actions. In this protocol, we utilized 'antpot 1 H'-MRS to examine the DLPFC of adult and adolescent bipolar patients in order to identify possible abnormal concentrations of NAA and inositol among the patients...
Subject(s)
Humans , Adolescent , Adult , Middle Aged , Prefrontal Cortex/metabolism , Bipolar Disorder/etiology , Magnetic Resonance Spectroscopy/methods , Inositol/analysisABSTRACT
A fosfolipase A2 (PLA2) é a enzima chave no metabolismo dos fosfolipídios das membranas celulares. Nós, bem como outros autores (Noponen e cols.(19)), descrevemos que a atividade da PLA2 no soro e no plasma de pacientes esquizofrênicos está aumentada quando comparada com a de controles psiquiátricos e normais. Este aumento na atividade da PLA2 pode ser inibido através do tratamento com neurolépticos. A degradação dos fosfolipídios da membrana pela PLA2 dá origem a produtos citotóxicos tais como a lisofosfatidilcolina (LPC). Numa série de estudos independentes, constatamos que as plaquetas de pacientes esquizofrênicos apresentam atividade aumentada da PLA2, conteúdo de fosfolipídios de membrana diminuído e concentrações de LPC aumentadas, sugerindo a ocorrência de degradação acelerada dos fosfolipídios no transtorno esquizofrênico. Para esclarecer as ações da PLA2 no cérebro, nós investigamos os efeitos produzidos por aplicações intracerebrais de PLA2 na neurotransmissão dopaminérgica em ratos, utilizando o modelo do comportamento rotacional de Ungerstedt. Os movimentos circulares induzidos por agonistas DA após aplicações unilaterais de PLA2 na pars compacta da substantia nigra foram registrados. A administração de apomorfina uma, três e cinco semanas após a injeção intranigral de PLA2 induziu rotações contralaterais, indicando que a aplicação de PLA2 havia produzido uma inibição duradoura da via dopaminérgica nigroestriatal ipsilateral. Tomados em conjunto, nossos achados sugerem que (a) pelo menos um subgrupo de pacientes esquizofrênicos apresenta atividade aumentada de PLA2 e, em conseqüência, degradação acelerada dos fosfolipídios da membrana plaquetária, e (b) em experimentos animais, a aplicação intranigral de PLA2 inibiu a atividade dopaminérgica. Qual é a relação entre estes achados e a biologia da esquizofrenia? Uma hipótese segundo a qual os pacientes esquizofrênicos apresentariam atividade dopaminérgica diminuída no córtex frontal já foi aventada. Estudos espectrográficos recentes evidenciaram uma degradação acelerada de fosfolipídios de membrana no córtex frontal de esquizofrênicos. A atividade aumentada da PLA2 poderia acelerar a metabolização de fosfolipídios no córtex frontal e assim contribuir para a postulada hipoatividade dopaminérgica do sistema mesocórticoðpréðfrontal na esquizofrenia